Search

Karyopharm Therapeutics Inc

Closed

SectorHealthcare

7.05 -2.22

Overview

Share price change

24h

Current

Min

7.03

Max

7.96

Key metrics

By Trading Economics

Income

80M

-22M

Sales

987K

35M

EPS

-1.24

Profit margin

-63.857

Employees

228

EBITDA

8M

-9.8M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+52.67% upside

Market Stats

By TradingEconomics

Market Cap

-29M

169M

Previous open

9.27

Previous close

7.05

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

22 lip 2026, 18:41 UTC

Social Media

Karyopharm Therapeutics shares are declining amid market caution and rising crude oil prices. RBC Capital reaffirmed its Outperform rating with a $16 price target.

21 lip 2026, 20:12 UTC

Karyopharm Therapeutics shares are lower in after-market hours, with no specific news driving the decline despite positive sentiment in U.S. markets.

20 lip 2026, 23:01 UTC

News

Karyopharm Therapeutics shares fell in after-market hours following the announcement of a leadership cash retention program aimed at key executives.

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

52.67% upside

12 Months Forecast

Average 12 USD  52.67%

High 16 USD

Low 7 USD

Based on 4 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

3

Buy

1

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat